Published in J Clin Invest on June 01, 2013
Transposable Elements and DNA Methylation Create in Embryonic Stem Cells Human-Specific Regulatory Sequences Associated with Distal Enhancers and Noncoding RNAs. Genome Biol Evol (2015) 0.79
Fluorescence-guided surgery of retroperitoneal-implanted human fibrosarcoma in nude mice delays or eliminates tumor recurrence and increases survival compared to bright-light surgery. PLoS One (2015) 0.79
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol (2010) 12.64
Genome regulation by long noncoding RNAs. Annu Rev Biochem (2012) 11.70
Molecular mechanisms of long noncoding RNAs. Mol Cell (2011) 11.44
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst (2003) 11.27
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest (2005) 5.90
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol (2011) 5.27
Epigenetic regulation by long noncoding RNAs. Science (2012) 4.74
2006 National Hospital Discharge Survey. Natl Health Stat Report (2008) 3.76
Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst (2010) 2.45
Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders. Cell Cycle (2011) 2.19
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol (2012) 2.12
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood (2012) 1.78
Laser-Activated Gene Silencing via Gold Nanoshell-siRNA Conjugates. ACS Nano (2009) 1.61
Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res (2010) 1.60
Phenotype-defining functions of multiple non-coding RNA pathways. Cell Cycle (2008) 1.57
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci Transl Med (2012) 1.42
Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PLoS One (2012) 1.33
Discovering the first microRNA-targeted drug. J Cell Biol (2012) 1.26
Uncovering the role of genomic "dark matter" in human disease. J Clin Invest (2012) 1.26
Multicolor microRNA FISH effectively differentiates tumor types. J Clin Invest (2013) 1.16
Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle progression/differentiation pathways in multiple common human disorders. Cell Cycle (2009) 1.16
Target mRNA inhibition by oligonucleotide drugs in man. Nucleic Acids Res (2012) 0.89
Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide. Br J Clin Pharmacol (2011) 0.87
Photonic gene circuits by optically addressable siRNA-Au nanoantennas. ACS Nano (2012) 0.86
DNA zipper-based tweezers. Langmuir (2011) 0.84
Transcriptional targeting by microRNA-polycomb complexes: a novel route in cell fate determination. Cell Cycle (2012) 0.83
Quantitative analysis of survivin protein expression and its therapeutic depletion by an antisense oligonucleotide in human lung tumors. Mol Ther Nucleic Acids (2012) 0.78